IDT Reports Fiscal 2018 Q1 Financial Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
109
IDT Reports Fiscal 2018 Q1 Financial Results

SAN JOSE, CALIFORNIA--(Marketwired - July 31, 2017) - Integrated Device Technology, Inc. (IDT ® ) (NASDAQ:IDTI) today announced results for the fiscal first quarter 2018, ended July 2, 2017.

"First quarter fiscal 2018 revenue increased by 12 percent sequentially, driven by our GigPeak acquisition plus broad organic growth across each of our end markets," said Greg Waters, president and chief executive officer. "We believe that IDT is positioned for continued revenue growth as the fiscal year progresses and expect to see acceleration in profit margin expansion and cash flows in the second half."

Recent Business Highlights - Consumer

  • IDT partnered with LG to enable wireless charging electronics in LG's flagship smartphones (LG G6).
  • IDT and Samsung teamed up again to bring rapid wireless charging to Samsung's Galaxy S8 and S8+ models. The wireless power technology partnership on the Galaxy S8 is significant and continues the integration of magnetic secure transmission (MST) payment technology.

Recent Business Highlights - Communications

  • IDT announced its IDT® 8T49N240, a highly-programmable clock generator and jitter attenuator IC featuring less than 200fs of phase noise that provides valuable system design margin for 10Gbps interfaces in wireline and wireless communication networks. The additional phase noise margin alleviates system design constraints, allowing engineers to reduce bit error rates (BER) while decreasing overall system costs.
  • IDT won Ericsson Semiconductor Supplier Award 2017 for excellent and consistent performance and company's support of technology leadership in mobile broadband and evolution to 5G.

Recent Business Highlights - Computing

  • IDT introduced new flash memory expander to allow customers the ability to increase solid state drive (SSD) memory at a reduced cost. The IDT MX0141V is the first 1:4 bidirectional multiplexer explicitly designed for this application. The MX0141V permits the expansion of SSD memory without the need for additional controllers and is designed for datacenter, enterprise and consumer memory subsystems.
  • IDT announced sampling of its 4RCD0232K register and 4DB0232K data buffer to customers and ecosystem partners. This chipset combines new features that were included in the latest generation of the JEDEC standard defined for 3200MT/s capability devices which include decision feedback equalization (DFE), dedicated NVDIMM communication ports and fine granularity output signal ring-back control. This chipset also consumes the lowest power of any DDR4 chipset in the industry today.

Recent Business Highlights - Auto and Industrial

  • IDT exhibited Advanced Sensing Technologies at SENSOR+TEST 2017 in Nurnberg, Germany. Technologies included: ZMID520x inductive position sensor, ZSSC4175 automotive sensor signal conditioner for dual voltage source sensor inputs with SENT or I2C output, ZSSC4165 automotive senor signal conditioner for dual resistive bridges with SENT or I2C output, ZSSC3018 sensor signal conditioner for high-accuracy amplification and analog-to-digital conversion of differential or pseudo-differential input signal and wireless charging solutions designed for automotive applications.
  • IDT presented Contactless Position Sensors at Sensors Expo 2017 in San Jose, California. Sensors displayed included the innovative IDT® ZMID520x inductive position sensors that are AEC-Q100-qualified, magnet-free sensors ideal for a variety of automotive, industrial and consumer applications.

The following highlights the Company's financial performance on both a GAAP and supplemental non-GAAP basis. The Company provides supplemental information regarding its operating performance on a non-GAAP basis that excludes certain gains, losses and charges which occur relatively infrequently and which management considers to be outside our core operating results. Non-GAAP results are not in accordance with GAAP and may not be comparable to non-GAAP information provided by other companies. Non-GAAP information should be considered a supplement to, and not a substitute for, financial statements prepared in accordance with GAAP. A complete reconciliation of GAAP to non-GAAP results is attached to this press release.

  • Revenue for the fiscal first quarter of 2018 was $196.7 million. This compared with $175.7 million reported last quarter, and $192.1 million reported in the same period one year ago.
  • GAAP net income for the fiscal first quarter of 2018 was $16.7 million, or $0.12 per diluted share, versus GAAP net income of $30.2 million or $0.22 per diluted share last quarter, and GAAP net income of $20.9 million or $0.15 per diluted share in the same period one year ago. Fiscal first quarter GAAP results include $17.8 million in acquisition and restructuring charges, $11.8 million in stock-based compensation, $3.9 million in non-cash interest expense, $1.7 million in certain unrealized foreign exchange gain and $3.3 million provision in related tax effects.
  • Non-GAAP net income for the fiscal first quarter of 2018 was $45.3 million or $0.33 per diluted share, compared with non-GAAP net income of $48.1 million or $0.35 per diluted share last quarter, and non-GAAP net income of $51.2 million or $0.36 per diluted share reported in the same period one year ago.
  • GAAP gross profit for the fiscal first quarter of 2018 was $110.0 million, or 55.9 percent, compared with GAAP gross profit of $101.7 million or 57.9 percent last quarter, and $108.3 million, or 56.4 percent, reported in the same period one year ago. Non-GAAP gross profit for the fiscal first quarter of 2018 was $120.7 million, or 61.4 percent, compared with non-GAAP gross profit of $106.1 million, or 60.4 percent last quarter, and $117.9 million, or 61.3 percent, reported in the same period one year ago.
  • GAAP R&D expense for the fiscal first quarter of 2018 was $48.4 million, compared with GAAP R&D expense of $35.5 million last quarter, and $49.6 million reported in the same period one year ago. Non-GAAP R&D expense for the fiscal first quarter of 2018 was $40.3 million, compared with non-GAAP R&D expense of $31.0 million last quarter, and $37.7 million in the same period one year ago.
  • GAAP SG&A expense for the fiscal first quarter of 2018 was $41.9 million, compared with GAAP SG&A expense of $36.2 million last quarter, and $38.8 million in the same period one year ago. Non-GAAP SG&A expense for the fiscal first quarter of 2018 was $30.8 million, compared with non-GAAP SG&A expense of $27.2 million last quarter, and $28.3 million in the same period one year ago.

Webcast and Conference Call Information

Investors may listen to the live call at 1:30 p.m. Pacific Time on July 31, 2017 by calling (888) 308-4493. The access code is 45266463. Investors may listen to a live or replay webcast of the Company's quarterly financial conference call at http://ir.idt.com/ . The live webcast will begin at 1:30 p.m. Pacific Time on July 31, 2017. The webcast replay will be available after 4:30 p.m. Pacific Time on July 31, 2017 for one week.

IDT's next regularly scheduled Quiet Period will begin September 18, 2017, during which time IDT representatives will not comment on IDT's business outlook, financial results or expectations. The Quiet Period will extend until the day when IDT's second quarter fiscal 2018 earnings release is published.

About IDT

Integrated Device Technology, Inc. develops system-level solutions that optimize its customers' applications. IDT's market-leading products in RF, timing, wireless power transfer, serial switching, interfaces and sensing solutions are among the company's broad array of complete mixed-signal solutions for the communications, computing, consumer, automotive and industrial segments. Headquartered in San Jose, Calif., IDT has design, manufacturing, sales facilities and distribution partners throughout the world. IDT stock is traded on the NASDAQ Global Select Stock Market® under the symbol "IDTI." Additional information about IDT is accessible at www.IDT.com . Follow IDT on Facebook , LinkedIn , Twitter , YouTube and Google+ .

Forward Looking Statements

Investors are cautioned that forward-looking statements in this release, including but not limited to statements regarding demand for Company products, anticipated trends in Company sales, expenses and profits, involve a number of risks and uncertainties that could cause actual results to differ materially from current expectations. Risks include, but are not limited to, global business and economic conditions, fluctuations in product demand, manufacturing capacity and costs, inventory management, competition, pricing, patent and other intellectual property rights of third parties, timely development and introduction of new products and manufacturing processes, dependence on one or more customers for a significant portion of sales, successful integration of acquired businesses and technology, availability of capital, cash flow and other risk factors detailed in the Company's Securities and Exchange Commission filings. The Company urges investors to review in detail the risks and uncertainties in the Company's Securities and Exchange Commission filings, including but not limited to the Annual Report on Form 10-K for the fiscal year ended April 3, 2016. All forward-looking statements are made as of the date of this release and the Company disclaims any duty to update such statements.

Non-GAAP Reporting

To supplement its consolidated financial results presented in accordance with GAAP, IDT uses non-GAAP financial measures which are adjusted from the most directly comparable GAAP financial measures to exclude certain items, as described in detail below. Management believes that these non-GAAP financial measures reflect an additional and useful way of viewing aspects of the Company's operations that, when viewed in conjunction with IDT's GAAP results, provide a more comprehensive understanding of the various factors and trends affecting the Company's business and operations. It should also be noted that IDT's non-GAAP information may be different from the non-GAAP information provided by other companies. Non-GAAP financial measures used by IDT include:

  • Cost of revenues;
  • Gross profit;
  • Research and development expenses;
  • Selling, general and administrative expenses;
  • Interest and other income (expense);
  • Provision for (benefit from) income taxes;
  • Operating income;
  • Net income;
  • Diluted net income per share; and
  • Weighted average shares outstanding - diluted

The Company presents non-GAAP financial measures because the investor community uses non-GAAP results in its analysis and comparison of historical results and projections of the Company's future operating results. These non-GAAP results exclude acquisition related expense, restructuring and divestiture related costs (gain), share-based compensation expense, results from discontinued operations, and certain other expenses and benefits. Management uses these non-GAAP measures to manage and assess the profitability of the business. These non-GAAP results are also consistent with the way management internally analyzes IDT's financial results.

There are limitations in using non-GAAP financial measures because they are not prepared in accordance with GAAP and may be different from non-GAAP financial measures used by other companies. The presentation of non-GAAP financial information is not meant to be considered in isolation or as a substitute for the most directly comparable GAAP financial measures. The non-GAAP financial measures supplement, and should be viewed in conjunction with, GAAP financial measures. Investors should review the reconciliations of the non-GAAP financial measures to their most directly comparable GAAP financial measures as provided in the accompanying press release.

As presented in the "Reconciliation of GAAP to Non-GAAP" tables in the accompanying press release, each of the non-GAAP financial measures excludes one or more of the following items:

Acquisition related . Acquisition-related charges are not factored into management's evaluation of potential acquisitions or IDT's performance after completion of acquisitions, because they are not related to the Company's core operating performance. Adjustments of these items provide investors with a basis to compare IDT's performance to other companies without the variability caused by purchase accounting. Acquisition-related expenses primarily include:

  • Amortization of acquisition related intangibles, which include acquired intangibles such as purchased technology, patents, customer relationships, trademarks, backlog and non-compete agreements.
  • Acquisition related costs such as legal, accounting and other professional or consulting fees directly related to an acquisition.
  • Fair market value adjustment to acquired inventory sold.

Restructuring related . Restructuring charges primarily relate to changes in IDT's infrastructure in efforts to reduce costs and expenses (gains) associated with strategic divestitures and restructuring in force actions. Restructuring charges (gains) are excluded from non-GAAP financial measures because they are not considered core operating activities. Although IDT has engaged in various restructuring activities in the past, each has been a discrete event based on a unique set of business objectives. As such, management believes that it is appropriate to exclude restructuring charges (gains) from IDT's non-GAAP financial measures as it enhances the ability of investors to compare the Company's period-over-period operating results. Restructuring-related charges (gains) primarily include:

  • Severance and retention costs directly related to a restructuring action.
  • Facility closure costs consist of ongoing costs associated with the exit of our leased and owned facilities.
  • Gain on divestiture consists of gains recognized upon the strategic sale of business units.
  • Assets impairments including accelerated depreciation of certain assets no longer in use.

Other adjustments . These items are excluded from non-GAAP financial measures because they are not related to the core operating activities and on-going future operating performance of IDT. Excluding this data allows investors to better compare IDT's period-over-period performance without such expense, which IDT believes may be useful to the investor community.

Other adjustments primarily include:

  • Stock based compensation expense.
  • Compensation expense (benefit) - deferred compensation, consists of gains and losses on marketable equity securities related to our deferred compensation arrangements.
  • Non-cash interest expense, consists of amortization of issuance cost and accretion of discount related to the convertible notes.
  • Loss (gain) on deferred compensation plan securities represents the changes in the fair value of the assets in a separate trust that is invested in corporate owned life insurance under our deferred compensation plan.
  • Unrealized foreign currency gains and losses resulting from remeasurement of certain non-functional currency account balances.
  • Tax effects of non-GAAP adjustments. Non-GAAP tax calculation is based on estimated cash tax expense and reserves. The Company forecasts its annual cash tax liability and allocates the tax to each quarter in proportion to earnings for that period. This approach is designed to enhance the ability of investors to understand the impact of the Company's tax expense on its current operations, provide improved modeling accuracy, and substantially reduce fluctuations caused by GAAP to non-GAAP adjustments, which may not reflect actual cash tax expense.
  • Diluted weighted average shares non-GAAP adjustment, for purposes of calculating non-GAAP diluted net income per share, the GAAP diluted weighted average shares outstanding is adjusted to exclude the benefits of stock compensation expense attributable to future services not yet recognized in the financial statements that are treated as proceeds assumed to be used to repurchase shares under the GAAP treasury method.

IDT and the IDT logo are trademarks or registered trademarks of Integrated Device Technology, Inc. All other brands, product names and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.

INTEGRATED DEVICE TECHNOLOGY, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
(In thousands, except per share data)
Three Months Ended
July 2 April 2 July 3
2017 2017 2016
Revenues $ 196,713 $ 175,698 $ 192,128
Cost of revenues 86,675 74,026 83,779
Gross profit 110,038 101,672 108,349
Operating expenses:
Research and development 48,449 35,533 49,648
Selling, general and administrative 41,942 36,225 38,816
Total operating expenses 90,391 71,758 88,464
Operating income 19,647 29,914 19,885
Interest and other expense, net (3,915 ) (2,153 ) (2,496 )
Income before income taxes 15,732 27,761 17,389
Benefit from income taxes (982 ) (2,448 ) (3,558 )
Net income $ 16,714 $ 30,209 $ 20,947
Basic net income per share $ 0.13 $ 0.23 $ 0.16
Diluted net income per share $ 0.12 $ 0.22 $ 0.15
Weighted average shares:
Basic 133,302 133,309 133,934
Diluted 136,642 136,903 138,109
INTEGRATED DEVICE TECHNOLOGY, INC.
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (a)
(Unaudited)
(In thousands, except per share data)
Three Months Ended
July 2 April 2 July 3
2017 2017 2016
GAAP net income $ 16,714 $ 30,209 $ 20,947
GAAP diluted net income per share $ 0.12 $ 0.22 $ 0.15
Acquisition related:
Amortization of acquisition related intangibles 8,876 4,782 5,775
Acquisition related costs 2,225 2,223 -
Amortization of fair market value adjustment to inventory 4,081 407 2,395
Restructuring related:
Severance and retention costs (benefit) 653 (387 ) 11,918
Facility closure costs - - 19
Assets impairment and other 1,965 156 870
Other:
Stock-based compensation expense 11,820 10,266 10,515
Non-cash interest expense 3,892 3,393 3,268
Certain foreign exchange gain (1,675 ) - -
Compensation expense - deferred compensation plan 412 486 402
Gain on deferred compensation plan securities (360 ) (474 ) (392 )
Non-GAAP tax adjustments (3,341 ) (2,942 ) (4,540 )
Non-GAAP net income $ 45,262 $ 48,119 $ 51,177
GAAP weighted average shares - diluted 136,642 136,903 138,109
Non-GAAP adjustment 2,319 1,596 2,287
Non-GAAP weighted average shares - diluted 138,961 138,499 140,396
Non-GAAP diluted net income per share $ 0.33 $ 0.35 $ 0.36
GAAP gross profit $ 110,038 $ 101,672 $ 108,349
Acquisition related:
Amortization of acquisition related intangibles 5,682 3,116 3,415
Amortization of fair market value adjustment to inventory 4,081 407 2,395
Restructuring related:
Severance and retention costs (benefit) 196 (36 ) 2,430
Assets impairment and other - 156 336
Other:
Compensation expense - deferred compensation plan 97 114 148
Stock-based compensation expense 632 660 779
Non-GAAP gross profit $ 120,726 $ 106,089 $ 117,852
GAAP R&D expenses: $ 48,449 $ 35,533 $ 49,648
Restructuring related:
Severance and retention costs (45 ) (44 ) (7,334 )
Assets impairment and other (1,965 ) - (107 )
Other:
Compensation expense - deferred compensation plan (210 ) (248 ) (157 )
Stock-based compensation expense (5,963 ) (4,226 ) (4,308 )
Non-GAAP R&D expenses $ 40,266 $ 31,015 $ 37,742
GAAP SG&A expenses: $ 41,942 $ 36,225 $ 38,816
Acquisition related:
Amortization of acquisition related intangibles (3,194 ) (1,666 ) (2,360 )
Acquisition related costs (2,225 ) (2,223 ) -
Restructuring related:
Severance and retention benefit (costs) (412 ) 395 (2,154 )
Facility closure costs - - (18 )
Assets impairment and other - - (428 )
Other:
Compensation expense - deferred compensation plan (105 ) (124 ) (98 )
Stock-based compensation expense (5,225 ) (5,380 ) (5,428 )
Non-GAAP SG&A expenses $ 30,781 $ 27,227 $ 28,330
GAAP interest and other expense, net $ (3,915 ) $ (2,153 ) $ (2,496 )
Non-cash interest expense 3,892 3,393 3,268
Gain on deferred compensation plan securities (360 ) (474 ) (393 )
Certain foreign exchange gain (1,675 ) - -
Non-GAAP interest and other income (expense), net $ (2,058 ) $ 766 $ 379
GAAP benefit from income taxes $ (982 ) $ (2,448 ) $ (3,558 )
Non-GAAP tax adjustments 3,341 2,942 4,540
Non-GAAP provision for income taxes $ 2,359 $ 494 $ 982
(a) Refer to the accompanying "Notes to Non-GAAP Financial Measures" for a detailed discussion of management's use of non-GAAP financial measures.
INTEGRATED DEVICE TECHNOLOGY, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
July 2 April 2
(In thousands) 2017 2017
ASSETS
Current assets:
Cash and cash equivalents $ 144,533 $ 214,554
Short-term investments 213,661 191,492
Accounts receivable, net 103,433 89,312
Inventories 71,371 52,288
Prepayments and other current assets 14,157 13,054
Total current assets 547,155 560,700
Property, plant and equipment, net 84,696 80,961
Goodwill 420,117 306,925
Intangible assets, net 195,441 108,818
Deferred tax assets 93,936 85,831
Other assets 42,657 40,399
TOTAL ASSETS $ 1,384,002 $ 1,183,634
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable $ 41,266 $ 42,020
Accrued compensation and related expenses 23,552 26,624
Deferred income on shipments to distributors 2,218 1,985
Current portion of bank loan 2,000 -
Other accrued liabilities 20,843 20,205
Total current liabilities 89,879 90,834
Deferred tax liabilities 12,160 13,835
Convertible notes 288,978 285,542
Long-term bank loan, net 191,957 -
Other long-term liabilities 25,422 19,760
Total liabilities 608,396 409,971
Stockholders' equity 775,606 773,663
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 1,384,002 $ 1,183,634
Financial Contact: Suzanne Schmidt IDT Investor Relations (408) 284-6515 ir@idt.com Press Contact: Daniel Aitken IDT Senior Director of Corporate Marketing and Communications (408) 574-6480 daniel.aitken@idt.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

WIN Expands Global Family Support to 124 Countries

Updated Category News Views 55

WIN's Ambitious Global Expansion In the ever-twisting labyrinth of corporate benefits, WIN is stepping up its game. We're talking an expansion that balloons past traditional fertility offerings into a global medley of support services covering every conceivable family and health scenario. It ain’t just about making babies anymore. When you're dealing with 124 countries,...

Continue Reading
Protalix Unveils Promising Gout Therapy Data at ACR 2026

Updated Category News Views 31

A Glimmer of Hope for Gout Sufferers Uncontrolled gout patients may soon see a light at the end of the tunnel. Protalix BioTherapeutics (NYSE American: PLX) just rolled out data at the ACR Convergence 2026, underscoring the potential of their drug candidate, PRX-115. This revelation is a big deal for those grappling with gout that just won't quit, constantly pelted by...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 202

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
EICMA 2026: Groundbreaking Moves in Two-Wheel World

Updated Category News Views 71

Revving Up in Milan: A Record-Breaking EICMA If you're into two-wheelers as much as stocks, EICMA 2026 is where all the action is happening. They opened the door with a bang at Fiera Milano Rho, pulling off their biggest showcase yet. Ten halls packed to the brim, up from nine the previous year, creating buzz across the globe. Showcasing 765 exhibitors and 2,142 brands...

Continue Reading
New Leadership at Reactive Tech: Claudio Facchin Steps In

Updated Category News Views 154

Facchin Joins Reactive Technologies: Power Play or Predictable Move? Let me tell you, the energy sector ain’t for the faint-hearted—especially when you’re talking grid stability. Reactive Technologies just tossed an ace on the table, appointing Claudio Facchin as the new Board Chairman. If you've been around the block, you might recognize Facchin's name from his...

Continue Reading
Leatt Gears Up for Q3 Results Conference Call

Updated Category News Views 106

A good heads-up, folks, isn't just about keeping helmets snug—it’s about knowing when to cash in, especially when Leatt Corporation's got their Q3 results ready to drop. November 12 is the big day, so circle that on your calendars. They're rolling out the numbers before the market even gets its coffee, possibly nudging the ticker, OTCQB:LEAT, in a ripple you’ll want...

Continue Reading
Target Hospitality's Growth and Earnings Analysis Q3 2026

Updated Category News Views 64

Strategic Transformation: A Mixed Bag of Results In the raucous world of high-stakes business, folks, Target Hospitality Corp. (NASDAQ: TH) is making quite the noise. For Q3 2026, they trumpeted a juicy $129.1 million in revenue, which is a solid notch up by 30% from a year before. Yet, like a seasoned trader facing a knife-edge call, they're handling a bittersweet...

Continue Reading
Energenesis Tackles Space Anemia with ATP Boost

Updated Category News Views 47

Gearing Up for Space Medicine: Enter Energenesis With the cosmic frontier drawing investor eyes and day-to-day operations inching skyward, here comes Energenesis Biomedical (TWSE: 6657), poking its head into space medicine. This isn’t just another biotech firm looking to throw drugs at terrestrial problems. No, Energenesis shot its shot at TASTI 2026 with its...

Continue Reading
Veterinary Stories Transform Pet Care in New Docuseries

Updated Category News Views 132

Peeling Back the Scrubs: Hidden Heroes in Vet Medicine Everyone's all-hands-on-deck when it's your furball on the line, but how much do you really know about what happens in those vet offices? Finally, National Veterinary Associates (NVA) is unzipping that mystery with a no-bones-about-it docuseries, Advancing Veterinary Medicine: Our Stories, right out of Austin, Texas....

Continue Reading
Zabalafin Hydrogel: Promise in Treating Atopic Dermatitis

Updated Category News Views 55

Pioneering a New Path in Dermatology Treatment In the world of dermatology, finding a topical solution that tackles the full spectrum of atopic dermatitis (AD) is as rare as hens' teeth. But here's a twist—in a recent research paper gracing the Journal of Drugs in Dermatology, Alphyn Biologics sheds light on their unique contender, Zabalafin Hydrogel. This ain't your...

Continue Reading

Top 5 Most Recently Viewed Articles

Qatar Airways Reveals New Lounge and Terminal at JFK Airport

Updated Category News Views 254

Qatar Airways Expands Presence at JFK Airport Qatar Airways is set to enhance its operations at John F. Kennedy International Airport by moving to the New Terminal One, which promises a first-of-its-kind experience for travelers in the United States. This airline, renowned for its exceptional service, is preparing to introduce a dedicated lounge in 2026, significantly...

Continue Reading
Venture Global Faces Class Action Amid Legal Challenges

Updated Category News Views 227

Venture Global Faces Legal Action Venture Global, Inc. has recently been embroiled in a securities class action lawsuit filed in the Southern District of New York. The lawsuit pertains to all individuals or entities who acquired Venture's securities during its initial public offering around January 2025, seeking to recover damages under federal securities laws. Claims of...

Continue Reading
Join Aclaris Therapeutics' R&D Day on Immuno-Inflammatory Gaps

Updated Category News Views 151

Aclaris Therapeutics R&D Day Focused on Patient Needs Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a biopharmaceutical organization based in Pennsylvania, is set to host its highly anticipated R&D Day. This event is dedicated to exploring the evolving landscape of immuno-inflammatory diseases and the innovative solutions that the company is developing. The R&D Day will take...

Continue Reading
Cloudelligent Achieves Sixth Ranking in Global MSP List

Updated Category News Views 137

Cloudelligent Celebrates Top Ranking in MSP 501 Cloudelligent, a prominent Managed Cloud Services provider, has reached an impressive milestone by being recognized as the sixth-ranked company on Channel Futures' prestigious MSP 501 list for the year. This distinction is not merely a testament to their robust performance; it underscores their relentless commitment to...

Continue Reading
Lithia Motors Sees Earnings Growth, Yet Shares Decline

Updated Category News Views 116

Lithia Motors Reports Strong Financial Performance Why are Lithia Motors, Inc.‘s shares slipping despite a substantial earnings beat and impressive profitability growth? As investors grapple with mixed signals from the company’s latest financial performance, the story behind the numbers holds the key to understanding market reactions. Lithia Motors shares are trading...

Continue Reading